Business · 28/08/1998Updated: 10/17/2026 · 1 min read
FDA Approves New Dosage Form for Neomycin Sulfate to Treat Colibacillosis in Livestock
Summary
The US Food and Drug Administration (FDA) has amended animal drug regulations to reflect approval of a supplemental application by Phoenix Scientific, Inc. for a new dosage form of neomycin sulfate to treat colibacillosis in cattle, pigs, sheep, and goats.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →